Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Neoplasms and OPRD1[original query] |
---|
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 2011 May 152 (5): 1139-45. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers P M, Kaasa S, , |
Analgesia and central side-effects: two separate dimensions of morphine response. British journal of clinical pharmacology 2012 Oct . Droney JM, Gretton SK, Sato H, Ross JR, Branford R, Welsh KI, Cookson W, Riley J |
Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids. Clinical and translational gastroenterology 2015 6 e90. Laugsand Eivor A, Skorpen Frank, Kaasa Stein, Sabatowski Rainer, Strasser Florian, Fayers Peter, Klepstad P |
Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients. Basic & clinical pharmacology & toxicology 2018 12 124 (4): 439-448. Muriel Javier, Margarit César, Barrachina Jordi, Ballester Pura, Flor Andrea, Morales Domingo, Horga José F, Fernández Eduardo, Peiró Ana |
[Effect of opioid-related gene polymorphisms on patients with high-dose opioid-tolerant cancer pain]. Zhonghua yi xue za zhi 2019 Dec 99 (47): 3720-3724. Xie G L, Zhang W, Li Z G, Guo D P, Liu |
Pan-Cancer Analysis and Validation of Opioid-Related Receptors Reveals the Immunotherapeutic Value of Toll-Like Receptor 4. International journal of general medicine 2023 11 16 5527-5548. Shaoping Wu, Junnan Chen, Enmin Huang, Yongfa Zha |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: